Case Study: National Oncologic Pet Registry

The National Oncologic PET Registry (NOPR) arose in response to a Centers for Medicare and Medicaid Services (CMS) proposal to expand cancer-related coverage of positron emission tomography (PET) using f-18 fluoro deoxyglucose (FDG). Whereas FDG-PET was CMS-approved for only a limited number of cancers, CMS agreed to conditional coverage of most cancers and related indications for those patients enrolled in a clinical registry evaluating the impact of PET on cancer management. Submitted by ACR Image Metrix